{
    "title": "Esperion says cholesterol drug gets U.S. approval; eyes $10 per pill pricing",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8030595/Esperions-cholesterol-drug-gets-U-S-approval-priced-10-pill.html",
    "date": "2020-02-21",
    "keywords": [
        "drug",
        "cholesterol",
        "company",
        "esperion",
        "treatment",
        "acid",
        "approval",
        "ldl",
        "dania",
        "trisha",
        "roy",
        "liver",
        "risk",
        "pill",
        "story",
        "analyst",
        "heart",
        "half",
        "nadeem",
        "friday",
        "health",
        "nonstatin",
        "sale",
        "country",
        "bempedoic",
        "lowdensity",
        "synthesis",
        "cardiovascular",
        "statement",
        "brand",
        "name",
        "nexletol",
        "prescription",
        "march",
        "derisking",
        "milestone",
        "transition",
        "clinicalstage",
        "commercialstage",
        "michael",
        "food",
        "administration",
        "fall",
        "placebo",
        "buildup",
        "disease",
        "check",
        "pfizer",
        "lipitor",
        "muscle",
        "pain",
        "nausea",
        "dysfunction",
        "onceaday",
        "statin",
        "today",
        "officer",
        "tim",
        "mayleben",
        "access",
        "sa",
        "regeneron",
        "praluent",
        "amgen",
        "incs",
        "repatha",
        "year",
        "derek",
        "archila",
        "peak",
        "marketing",
        "application",
        "combination",
        "fda",
        "decision",
        "trading",
        "bell",
        "reporting",
        "joseph",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}